Delivery Order SPE2DB22D2211-SPE2DB25FSCJF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $44,569.10 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets (30-count units) under a firm fixed price contract. This non-competitive delivery order was issued on August 26, 2025, with an ultimate completion date of August 27, 2025, and will be performed at the vendor's facility in Conshohocken, Pennsylvania. Biktarvy is an antiretroviral medication used in HIV treatment, reflecting the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order valued at $8,351.68 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This firm fixed price delivery order, with a completion date of July 30, 2025, represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Biktarvy is an antiretroviral medication used in HIV treatment, reflecting the...
- The Defense Logistics Agency awarded a $23,458.54 delivery order to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical distributor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $39,414.39 to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) on September 12, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price, competitively awarded delivery order represents a non-set-aside procurement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Biktarvy is an antiretroviral medication used in the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,481.50 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order was issued on September 3, 2025, with an ultimate completion date of September 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract includes no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $23,384.88 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets (30-count units) under a firm fixed-price contract. The award was made on August 5, 2025, with an ultimate completion date of August 6, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for $43,157.04 to supply Biktarvy 50-200-25 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract was executed on September 2, 2025, with an ultimate completion date of September 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Biktarvy is an antiretroviral medication used in the treatment of HIV,...
- The Defense Logistics Agency awarded a delivery order valued at $7,243.43 to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) on June 2, 2025, with a completion date of June 3, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency awarded a $34,787.81 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 25, 2025. The contract is performed from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $57,995.91 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units), with an ultimate completion date of August 28, 2025. This contract employs firm fixed pricing and carries no set-aside designation, reflecting competitive procurement through open competition. The order is issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSCJFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $63,577.58 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order was issued on August 6, 2025, with an ultimate completion date of August 7, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the company's demonstrated capability to compete in open federal procurement processes. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. Biktarvy is an antiretroviral medication used in HIV treatment, representing part of AmerisourceBergen's extensive portfolio of specialty medications and brand-name pharmaceuticals delivered to the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $63.6k | 8/6/25 |